Xolair

Novartis plots more than 100 layoffs in New Jersey as part of rework to Xolair, cancer combo field sales teams
Fierce Pharma
Tue, 11/26/24 - 10:26 pm
Novartis
layoffs
New Jersey
Xolair
Novartis and Genentech’s Xolair is rising rapidly on TV
Medical Marketing and Media
Thu, 08/29/24 - 06:11 pm
Novartis
Genentech
Xolair
television ads
Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer Coverage
Forbes
Wed, 03/6/24 - 11:25 am
Roche
Novartis
Xolair
insurers
food allergies
Roche's Xolair reduces reactions to severe food allergies in study
Reuters
Sun, 02/25/24 - 05:36 pm
Roche
Novartis
Xolair
clinical trials
food allergies
FDA approves Roche, Novartis' Xolair to prevent severe outcomes from common food allergies
Fierce Pharma
Sun, 02/18/24 - 08:31 pm
Roche
Novartis
Xolair
food allergies
FDA
Roche, Novartis move Xolair closer to FDA finish line for food allergies
Fierce Pharma
Tue, 12/19/23 - 11:10 pm
Roche
FDA
Xolair
food allergies
Novartis
Scratching the surface of the urticaria pipeline
EP Vantage
Thu, 07/20/23 - 10:00 am
chronic urticaria
Sanofi
Dupixent
Regeneron
Novartis
Roche
Xolair
Allakos
AstraZeneca
Celldex Therapeutics
Blow for Novartis as ligelizumab can’t top Xolair in phase 3
Pharmaforum
Mon, 12/20/21 - 11:01 am
Novartis
ligelizumab
clinical trials
chronic spontaneous urticaria
Xolair
Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair
BioSpace
Tue, 04/13/21 - 10:03 pm
Genentech
Novartis
FDA
Xolair
allergies
Which asthma biologic do docs prefer? It's not that simple: analyst
Fierce Pharma
Sat, 11/23/19 - 03:47 pm
asthma
Roche
Novartis
Xolair
Sanofi
Regeneron
Dupixent
physicians
Novartis' ligelizumab outperforms Roche's Xolair in chronic urticaria clearance
Pharmafile
Wed, 10/9/19 - 11:10 pm
Novartis
clinical trials
ligelizumab
Roche
Xolair
chronic urticaria
Novartis gets EC approval for self-administration of Xolair across all indications
Pharmaceutical Business Review
Fri, 12/14/18 - 02:30 pm
Novartis
Xolair
severe allergic asthma
chronic spontaneous urticaria
Novartis, aiming to protect blockbuster sales, advances Xolair follow-up to phase 3
Fierce Pharma
Thu, 12/6/18 - 12:55 pm
Novartis
Xolair
ligelizumab
hives
clinical trials
Roche, Novartis grab FDA OK for new version of aging blockbuster Xolair
Fierce Pharma
Wed, 10/3/18 - 11:49 am
Roche
Novartis
Xolair
Xolair pen
FDA
Roche's Xolair, challenged in asthma, wins 'breakthrough' in food allergies
Fierce Pharma
Mon, 08/13/18 - 05:53 pm
Novartis
Roche
Xolair
FDA
food allergies
Glaxo aims to lure patients from Novartis' Xolair with Nucala switching study
Fierce Pharma
Tue, 03/6/18 - 09:27 am
GSK
Novartis
Xolair
Nucala
asthma
Novartis funds app to boost Xolair in hives
Fierce Pharma
Mon, 05/23/16 - 09:35 pm
Novartis
mobile apps
Xolair
hives
GSK readies respiratory sales force to challenge Xolair in severe asthma
Fierce Pharma Marketing
Thu, 10/29/15 - 01:20 pm
GSK
Xolair
severe asthma
asthma
Nucala
Novartis
Cost watchdogs back Novartis' Xolair for big new market in chronic hives
Fierce Pharma
Thu, 03/12/15 - 09:36 pm
Novartis
Xolair
chronic hives
UK
NICE
FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters
Mon, 09/29/14 - 02:00 pm
FDA
Xolair
asthma
Roche
Genentech

Pages